CN107589162B - 一种基于铱配合物光电化学生物传感器的制备方法及应用 - Google Patents
一种基于铱配合物光电化学生物传感器的制备方法及应用 Download PDFInfo
- Publication number
- CN107589162B CN107589162B CN201710760878.9A CN201710760878A CN107589162B CN 107589162 B CN107589162 B CN 107589162B CN 201710760878 A CN201710760878 A CN 201710760878A CN 107589162 B CN107589162 B CN 107589162B
- Authority
- CN
- China
- Prior art keywords
- complex
- fibrin ferment
- hair clip
- iridium
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052741 iridium Inorganic materials 0.000 title claims abstract description 35
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 102000009123 Fibrin Human genes 0.000 claims abstract description 29
- 108010073385 Fibrin Proteins 0.000 claims abstract description 29
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229950003499 fibrin Drugs 0.000 claims abstract description 29
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000523 sample Substances 0.000 claims abstract description 21
- 238000001514 detection method Methods 0.000 claims abstract description 17
- 239000002184 metal Substances 0.000 claims abstract description 16
- 229910052751 metal Inorganic materials 0.000 claims abstract description 16
- 239000010931 gold Substances 0.000 claims abstract description 15
- 229910052737 gold Inorganic materials 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000009396 hybridization Methods 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 23
- 239000003446 ligand Substances 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 claims description 6
- 229960003151 mercaptamine Drugs 0.000 claims description 6
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 4
- 239000011149 active material Substances 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- QEDXSHCYPROEOK-UHFFFAOYSA-N 3-phosphanylpropanoic acid Chemical class OC(=O)CCP QEDXSHCYPROEOK-UHFFFAOYSA-N 0.000 claims description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 239000002356 single layer Substances 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 2
- 108060002716 Exonuclease Proteins 0.000 claims 1
- XEIPQVVAVOUIOP-UHFFFAOYSA-N [Au]=S Chemical compound [Au]=S XEIPQVVAVOUIOP-UHFFFAOYSA-N 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- VBVAVBCYMYWNOU-UHFFFAOYSA-N coumarin 6 Chemical compound C1=CC=C2SC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 VBVAVBCYMYWNOU-UHFFFAOYSA-N 0.000 claims 1
- 102000013165 exonuclease Human genes 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 13
- 230000004044 response Effects 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 108010052305 exodeoxyribonuclease III Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 15
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000012299 nitrogen atmosphere Substances 0.000 description 6
- 108090000190 Thrombin Proteins 0.000 description 5
- UYVZCGGFTICJMW-UHFFFAOYSA-N [Ir].[Au] Chemical compound [Ir].[Au] UYVZCGGFTICJMW-UHFFFAOYSA-N 0.000 description 5
- 239000000090 biomarker Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229960004072 thrombin Drugs 0.000 description 5
- 108091023037 Aptamer Proteins 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 230000005518 electrochemistry Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000004533 Endonucleases Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229960004756 ethanol Drugs 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000012447 hatching Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000002096 quantum dot Substances 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 229910004613 CdTe Inorganic materials 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- BVQAWSJMUYMNQN-UHFFFAOYSA-N dipyridophenazine Chemical compound C1=CC=C2C3=NC4=CC=CC=C4N=C3C3=CC=CN=C3C2=N1 BVQAWSJMUYMNQN-UHFFFAOYSA-N 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010003178 Arterial thrombosis Diseases 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 244000248349 Citrus limon Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 235000004237 Crocus Nutrition 0.000 description 1
- 241000596148 Crocus Species 0.000 description 1
- 241000522215 Dipteryx odorata Species 0.000 description 1
- 229910004042 HAuCl4 Inorganic materials 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910021638 Iridium(III) chloride Inorganic materials 0.000 description 1
- 101710094902 Legumin Proteins 0.000 description 1
- 108700011259 MicroRNAs Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 238000012455 bioassay technique Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical class ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical compound [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000002305 electric material Substances 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910021505 gold(III) hydroxide Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- -1 hexafluorophosphoric acid amine Chemical class 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002503 iridium Chemical class 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- LGZXYFMMLRYXLK-UHFFFAOYSA-N mercury(2+);sulfide Chemical compound [S-2].[Hg+2] LGZXYFMMLRYXLK-UHFFFAOYSA-N 0.000 description 1
- 239000002679 microRNA Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- NICDRCVJGXLKSF-UHFFFAOYSA-N nitric acid;trihydrochloride Chemical compound Cl.Cl.Cl.O[N+]([O-])=O NICDRCVJGXLKSF-UHFFFAOYSA-N 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 230000001443 photoexcitation Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- DANYXEHCMQHDNX-UHFFFAOYSA-K trichloroiridium Chemical compound Cl[Ir](Cl)Cl DANYXEHCMQHDNX-UHFFFAOYSA-K 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710760878.9A CN107589162B (zh) | 2017-08-30 | 2017-08-30 | 一种基于铱配合物光电化学生物传感器的制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710760878.9A CN107589162B (zh) | 2017-08-30 | 2017-08-30 | 一种基于铱配合物光电化学生物传感器的制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107589162A CN107589162A (zh) | 2018-01-16 |
CN107589162B true CN107589162B (zh) | 2019-07-23 |
Family
ID=61051347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710760878.9A Active CN107589162B (zh) | 2017-08-30 | 2017-08-30 | 一种基于铱配合物光电化学生物传感器的制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107589162B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108918872A (zh) * | 2018-07-25 | 2018-11-30 | 济南大学 | 一种检测凝血酶的纸基光致电化学免疫传感器的构建方法 |
CN110438202B (zh) * | 2019-08-15 | 2022-09-20 | 青岛科技大学 | 一种基于环金属Ir(III)配合物的凝血酶光电化学传感器的制备方法 |
CN111624338B (zh) * | 2020-06-06 | 2022-12-16 | 青岛科技大学 | 一种检测前列腺特异性抗原的光电化学免疫传感器的制备方法 |
CN113201580B (zh) * | 2021-04-28 | 2022-07-22 | 青岛科技大学 | 一种环金属铱配合物敏化NiO阴极光电化学生物传感器的制备方法 |
CN115078490B (zh) * | 2022-06-02 | 2024-04-30 | 青岛科技大学 | 一种用于检测CN–的铱(III)配合物敏化NiO光阴极的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102507689A (zh) * | 2011-10-19 | 2012-06-20 | 青岛科技大学 | 一种检测凝血酶的电化学发光传感器的制备方法及应用 |
CN104374765A (zh) * | 2014-11-17 | 2015-02-25 | 济南大学 | 一种电化学发光适配体传感器、其制备方法及其用途 |
-
2017
- 2017-08-30 CN CN201710760878.9A patent/CN107589162B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102507689A (zh) * | 2011-10-19 | 2012-06-20 | 青岛科技大学 | 一种检测凝血酶的电化学发光传感器的制备方法及应用 |
CN104374765A (zh) * | 2014-11-17 | 2015-02-25 | 济南大学 | 一种电化学发光适配体传感器、其制备方法及其用途 |
Non-Patent Citations (3)
Title |
---|
Cyclometalated Iridium Complex-Based Label-Free Photoelectrochemical Biosensor for DNA Detection by Hybridization Chain Reaction Amplification;Chunxiang Li 等;《Analytical Chemistry》;20150327;第87卷;第4284页-4290页,流程图1-3 |
Impact of Substituents on Excited-State and Photosensitizing Properties in Cationic Iridium(III) Complexes with Ligands of Coumarin 6;Shin-ya Takizawa 等;《Inorganic Chemistry》;20160822;第55卷;第8723-8733页,流程图1 |
Simple novel cyclometallated iridium complexes for potential application in dye-sensitized solar cells;Claudia Dragonetti 等;《Inorganica Chimica Acta》;20120322;第388卷;第163-167页 |
Also Published As
Publication number | Publication date |
---|---|
CN107589162A (zh) | 2018-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107589162B (zh) | 一种基于铱配合物光电化学生物传感器的制备方法及应用 | |
She et al. | Design strategy and recent progress of fluorescent probe for noble metal ions (Ag, Au, Pd, and Pt) | |
CN108318477B (zh) | 基于TiO2金属有机框架制备的电致化学发光探针及其对呕吐毒素的竞争型免疫传感方法 | |
CN108246271B (zh) | 一种用于2,4,6-三硝基苯酚检测的分子印迹聚合物微球的制备方法 | |
CN101458215B (zh) | 一种多联吡啶钌络合物的电化学发光适配子传感器及制法 | |
CN102507921B (zh) | 一种检测微囊藻毒素的方法 | |
CN101435778B (zh) | 一种直接用眼睛定性检测溶液中Cu2+的方法 | |
CN107543851B (zh) | 一种基于草酸银桥联三联吡啶钌纳米复合物的电化学发光传感器的制备方法及应用 | |
CN110982046B (zh) | 基于四苯乙烯的共轭微孔聚合物聚集诱导的电化学发光传感器及其制备方法和应用 | |
Cheng et al. | A coumarin-connected carboxylic indolinium sensor for cyanide detection in absolute aqueous medium and its application in biological cell imaging | |
CN106290514A (zh) | 一种基于硅酞菁功能化的TiO2介观晶体的黄曲霉毒素光电化学检测方法 | |
CN106324065A (zh) | 一种化学发光光致电化学传感器的制备及有机磷类农药检测 | |
CN107727714A (zh) | 一种基于碳纳米角及TiO2介晶纳米材料的比率型电化学发光免疫传感器的制备方法 | |
CN110530950A (zh) | 基于激子等离子体相互作用高效检测psa的纸基传感器的构建 | |
CN107589166B (zh) | 一种基于TiO2介观晶体的免标记型玉米赤霉烯酮光电化学检测方法和传感器 | |
CN102391947A (zh) | 一种多孔整体柱固定化酶微反应器的制备方法 | |
CN112852418B (zh) | 一种双发射比率荧光碳点及其制备方法和应用 | |
CN109608414A (zh) | 检测过氧亚硝酸根的荧光探针及其制备方法和应用 | |
CN102419319A (zh) | 对一氧化氮具有选择性荧光响应的基于硅纳米线的传感器 | |
CN110438202B (zh) | 一种基于环金属Ir(III)配合物的凝血酶光电化学传感器的制备方法 | |
Jia et al. | Target-triggered and controlled release plasmon-enhanced fluorescent AIE probe for conformational monitoring of insulin fibrillation | |
CN109142486B (zh) | 一种用于microRNA检测的光电化学生物传感器的制备方法 | |
CN108088828A (zh) | 一种双柱芳烃汞离子荧光传感器及其制备和应用 | |
CN110018146B (zh) | 一种基于荧光碳量子点检测钯离子的方法 | |
CN108774226B (zh) | 一种用于检测银离子的荧光探针及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230926 Address after: 230000 floor 1, building 2, phase I, e-commerce Park, Jinggang Road, Shushan Economic Development Zone, Hefei City, Anhui Province Patentee after: Dragon totem Technology (Hefei) Co.,Ltd. Address before: 266000 Songling Road, Laoshan District, Qingdao, Shandong Province, No. 99 Patentee before: QINGDAO University OF SCIENCE AND TECHNOLOGY Effective date of registration: 20230926 Address after: Room 501, Door 2, Building 3, No. 7 Liuhe Village, Kaifu District, Changsha City, Hunan Province, 410000 Patentee after: Wang Dengzhi Patentee after: Zhou Yan Address before: 230000 floor 1, building 2, phase I, e-commerce Park, Jinggang Road, Shushan Economic Development Zone, Hefei City, Anhui Province Patentee before: Dragon totem Technology (Hefei) Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240408 Address after: 102200 Floor 1-2, Building 8, Beiliu Village South (Beijing Boran Pharmaceutical Co., Ltd.), Liucun Town, Changping District, Beijing Patentee after: Deming Shenzhou Bioengineering (Beijing) Co.,Ltd. Country or region after: China Address before: Room 501, Door 2, Building 3, No. 7 Liuhe Village, Kaifu District, Changsha City, Hunan Province, 410000 Patentee before: Wang Dengzhi Country or region before: China Patentee before: Zhou Yan |